Table 3.
Summary of immunohistochemical staining
|
SAMPLES ID |
PRIMARY MAMMARY TUMOR |
LYMPH NODE METASTASIS |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ER* | PR* | c-erbB-2° | CK 14* | CK 5/6* | p63* | ER* | PR* | c-erbB-2° | CK 14* | CK 5/6* | p63* | |
|
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
|
2 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
|
3 |
1 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
|
5 |
0 |
1 |
3 |
1 |
1 |
1 |
0 |
1 |
3 |
1 |
1 |
0 |
|
6 |
1 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
|
7 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
0 |
|
8 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
|
9 |
1 |
1 |
3 |
1 |
1 |
1 |
0 |
0 |
3 |
1 |
1 |
0 |
|
10 |
1 |
1 |
3 |
1 |
1 |
1 |
1 |
1 |
3 |
1 |
1 |
0 |
|
11 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
|
12 |
1 |
0 |
2 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
|
13 |
1 |
0 |
2 |
1 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
|
14 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
1 |
1 |
0 |
|
15 |
0 |
0 |
2 |
1 |
1 |
0 |
0 |
0 |
3 |
1 |
1 |
0 |
|
16 |
1 |
0 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
|
17 |
0 |
1 |
2 |
1 |
1 |
0 |
0 |
1 |
2 |
1 |
1 |
0 |
|
18 |
0 |
0 |
2 |
1 |
1 |
1 |
0 |
0 |
2 |
0 |
0 |
0 |
|
19 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
| 20 | 0 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 1 |
*ER, PR, CK5/6, CK14, p63: 0= no immunoreactivity; 1= immunoreactivity. °c-erbB-2: 0= no immunoreactivity; 1= <10% positive cells; 2= 10 to 90% complete membranous immunostaining; 3= >90% complete membranous cell positivity.